✦ LIBER ✦

SCH 28080 is a lumenally acting, K+-site inhibitor of the gastric (H+ + K+)-ATPase

✍ Scribed by David J. Keeling; Shiona M. Laing; Jorg Senn-Bilfinger

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

SCH 28080 is a more selective inhibitor

✍ Winfried Beil; Ute Staar; Karl-Fr. Sewing 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 219 KB

SK&F 96067 is a reversible, lumenally ac

✍ D.J. Keeling; R.C. Malcolm; S.M. Laing; R.J. Ife; C.A. Leach 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 837 KB

Studies on the mechanism of action of th

✍ Cynthia K. Scott; Erin Sundell; Lorraine Castrovilly 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 872 KB

The gastric H,K-ATPase blocker lansopraz

✍ Andreas Schmarda; Patrick Dinkhauser; Martin Gschwentner; Markus Ritter; Johanne 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 455 KB

Ro 18-5364, a potent new inhibitor of th

✍ Kristine SIGRIST-NELSON; Anna KRASSO; Rita K. M. MÜLLER; Albert E. FISCHLI 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 708 KB

The effects of lansoprazole, a new H+,K+

✍ S. W. SANDERS; K. G. TOLMAN; P. A. GRESKI; D. E. JENNINGS; P. A. HOYOS; J. G. PA 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 761 KB